ERBB2 c.2567C>T ;(p.P856L)

Variant ID: 17-37881375-C-T

NM_004448.2(ERBB2):c.2567C>T;(p.P856L)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer.

Cancer Research And Treatment
Han, Mi-Ryung MR; Lee, Sug Hyung SH; Park, Jung Yoon JY; Hong, Hyosun H; Ho, Jung Yoon JY; Hur, Soo Young SY; Choi, Youn Jin YJ
Publication Date: 2020-07

Variant appearance in text: ERBB2: P856L
PubMed Link: 32106643
Variant Present in the following documents:
  • crt-2019-700-suppl4.pdf
View BVdb publication page



Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients.

Plos One
Koeppel, Florence F; Blanchard, Steven S; Jovelet, Cécile C; Genin, Bérengère B; Marcaillou, Charles C; Martin, Emmanuel E; Rouleau, Etienne E; Solary, Eric E; Soria, Jean-Charles JC; André, Fabrice F; Lacroix, Ludovic L
Publication Date: 2017

Variant appearance in text: ERBB2: Pro856Leu
PubMed Link: 29161279
Variant Present in the following documents:
  • Main text
  • pone.0188174.pdf
View BVdb publication page



Standardization of epidermal growth factor receptor (EGFR) measurement by quantitative immunofluorescence and impact on antibody-based mutation detection in non-small cell lung cancer.

The American Journal Of Pathology
Dimou, Anastasios A; Agarwal, Seema S; Anagnostou, Valsamo V; Viray, Hollis H; Christensen, Stephen S; Gould Rothberg, Bonnie B; Zolota, Vassiliki V; Syrigos, Konstantinos K; Rimm, David L DL
Publication Date: 2011-08

Variant appearance in text: HER-2: P856L
PubMed Link: 21722621
Variant Present in the following documents:
  • Main text
View BVdb publication page